Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14520869 | 1.00 | CCKBR (1.00) | CCKBRCCKAR | |
| SCHEMBL8946830 | 0.85 | CCKBR (0.74) | CCKBRCCKAR | |
| SCHEMBL8946684 | 0.85 | CCKBR (0.83) | CCKBRCCKAR | |
| SCHEMBL8946969 | 0.77 | CCKAR (0.61) | CCKBRCCKAR | |
| SCHEMBL1387839 | 0.73 | CCKBR (1.00) | CCKBR | |
| SCHEMBL21586582 | 0.71 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL6178977 | 0.71 | CCKBR (0.57) | CCKBRCCKAR | |
| SCHEMBL6176331 | 0.71 | CCKBR (0.55) | CCKBRCCKAR | |
| SCHEMBL8946841 | 0.71 | CCKBR (0.67) | CCKBRCCKAR | |
| SCHEMBL8946749 | 0.71 | CCKBR (0.73) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5585376-A | 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity | GLAXO WELLCOME INC. (US) | 1996-12-17 | — | — | US | claimed |
| EP-0694040-A1 | 1,5 BENZODIAZEPINE DERIVATIVES HAVING CCK AND/OR GASTRIN ANTAGONISTIC ACTIVITY | GLAXO WELLCOME INC. (US) | 1996-01-31 | — | — | EP | claimed |
| WO-1994024151-A1 | 1,5 BENZODIAZEPINE DERIVATIVES HAVING CCK AND/OR GASTRIN ANTAGONISTIC ACTIVITY | GLAXO INC. (US) | 1994-10-27 | — | — | WO | claimed |
| US-5585376-A | 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity | GLAXO WELLCOME INC. (US) | 1996-12-17 | — | — | US | disclosed |